
nContact Surgical Inc. is now nContact Inc.
The Morrisville, N.C.-based cardiac device manufacturer said its new name represents a move towards less invasive, endoscopic approaches for treating irregular heartbeat with epicardial ablation. The company’s surgical tools allow cardiologists to treat arrhythmias through a small midline abdominal incision, according to the company.
“By removing ‘Surgical’ from our company name, we are categorically affirming our mission to transform the ablation market and change the dialogue from individual surgical or catheter approaches to interdisciplinary and [epicardial]-only approaches that may achieve greater scientific and clinical endpoints,” CEO John Funkhouser said in prepared remarks.
In November, nContact raised $16 million in a Series D round to support its endoscopic cardiac ablation system for treating atrial fibrillation.